Literature DB >> 6581287

Methotrexate and folate content of erythrocytes in patients receiving oral vs intramuscular therapy with methotrexate.

B A Kamen, J S Holcenberg, K Turo, V M Whitehead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6581287     DOI： 10.1016/s0022-3476(84)80610-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  10 in total

1.  Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells.

Authors:  M A Kane; P C Elwood; R M Portillo; A C Antony; V Najfeld; A Finley; S Waxman; J F Kolhouse
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

2.  Current issues in the management of children with acute lymphocytic leukaemia.

Authors:  D Pinkel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

3.  Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Naomi J Winick; Pierre Wacker; Xiaomin Lu; Meenakshi Devidas; Jonathan J Shuster; Donald H Mahoney; Stephen J Lauer; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2012-01       Impact factor: 1.289

4.  Methotrexate in erythrocytes of patients with psoriasis.

Authors:  H Schrøder; E K Foged
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Methotrexate pharmacokinetics in age-fractionated erythrocytes.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.

Authors:  M L Graham; J J Shuster; B A Kamen; D L Cheo; M P Harrison; B G Leventhal; D J Pullen; V M Whitehead
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes.

Authors:  H Schrøder; K Fogh; T Herlin
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.

Authors:  H Schrøder; K Fogh
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment.

Authors:  H Schrøder; N Clausen; E Ostergaard; T Pressler
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.

Authors:  Natanja Oosterom; Robert de Jonge; Desiree E C Smith; Rob Pieters; Wim J E Tissing; Marta Fiocco; Bertrand D van Zelst; Marry M van den Heuvel-Eibrink; Sandra G Heil
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.